Gross Profit: Revenues from operations less the associated costs.
Cardiol Therapeutics Inc. (CRDL) Gross Profit data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-24.20M |
|
-- |
|
|
Gross Profit |
-- |
$24.56M |
|
$-24.56M |
|
$0.36M |
|
$-24.20M |
|
$-24.20M |
|
$-24.20M |
|
$-24.20M |
|
$-24.20M |
|
$-24.20M |
|
$-24.56M |
|
$-24.49M |
|
86.99M |
|
86.99M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$16.82M |
|
$0.08M |
|
$0.08M |
|
$16.90M |
|
$4.05M |
|
$0.06M |
|
$0.06M |
|
$4.11M |
|
$12.80M |
|
$12.80M |
|
$12.80M |
|
100.26M |
|
| Cash Flow Statement Financials | |
$-17.07M |
|
$-0.02M |
|
$11.12M |
|
$21.89M |
|
$15.33M |
|
$-6.56M |
|
$7.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.16 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-189.17% |
|
-189.17% |
|
-143.18% |
|
-188.25% |
|
$0.13 |
|
$-0.20 |
|
$-0.20 |
|